FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 142 filers reported holding FLEXION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,424,000 | +93.3% | 675,000 | +75.3% | 0.04% | +63.6% |
| Q4 2018 | $4,358,000 | -39.5% | 385,000 | 0.0% | 0.02% | -26.7% |
| Q3 2018 | $7,203,000 | +23.1% | 385,000 | +70.1% | 0.03% | +15.4% |
| Q2 2018 | $5,850,000 | +48.1% | 226,300 | +28.4% | 0.03% | +44.4% |
| Q1 2018 | $3,951,000 | -30.3% | 176,300 | -22.1% | 0.02% | -30.8% |
| Q4 2017 | $5,667,000 | +11.9% | 226,300 | +8.0% | 0.03% | +8.3% |
| Q3 2017 | $5,066,000 | +19.6% | 209,500 | 0.0% | 0.02% | +9.1% |
| Q2 2017 | $4,236,000 | +49.4% | 209,500 | +98.8% | 0.02% | +46.7% |
| Q1 2017 | $2,836,000 | +101.6% | 105,400 | +42.4% | 0.02% | +87.5% |
| Q4 2016 | $1,407,000 | +89.4% | 74,000 | +94.7% | 0.01% | +100.0% |
| Q3 2016 | $743,000 | +83.9% | 38,000 | +40.7% | 0.00% | +100.0% |
| Q2 2016 | $404,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |